MATERIALS AND METHODS As of April 12, 1973, more than 1,300 case studies have been
accessioned including 151 in stances of untreated Hodgkin's disease. This series does not …

RESULTS General. Of the 168 previously untreated patients with lymphoma forming the
basis for this report, 133 (78%) yielded one or more positive sites on scan and about 5% had …

Colloidal radioactive gold, Au 198 , has been used for several years in the palliative treatment
of patients with recurrent pleural and abdominal effusions caused by malignant neoplasm. …

Although the use of colloids to studybone marrow has gained some favor in clinical practice,
their value in establishing a specific diagnosis is limited. Now and then scanning combined …

In vivo labeling of platelets with S 35 has specific advantages: metabolic incorporation into
megakaryocytes provides a firm platelet label without elution; rapid excretion of …

Among the radioisotopes which have therapeutic value is radioactive gold, AU 198 . It has a
half-life of 2.8 days and decays with both beta and gamma emissions. One peculiar …

1.1. Pleural and ascitic fluids associated with malignant neoplasms have been studied in an
effort to clarify the mechanisms involved in intracavitary radiogold therapy. Following …

The answers about the clinical value of a new radiopharmaceutical are sometimes hard to
come by, or slow to emerge. Individual investigators accumulate cases slowly. They often …

The Oak Ridge Institute of Nuclear Studies (ORINS), a nonprofit corporation of 39 colleges
and universities, includes a Medical Division program supported by the Division of Biology …

MATERIALS AND METHODS The radiocolloidal gold was administered intravenously
through a gravity-drip apparatus, which has been described for intracavitary infusion. 1 The …